Karuna Therapeutics, Inc.
KRTX
Revenue
0.00
0.000.00%
-Assets
1.34B
▼-48.89M▼-3.53%
3 Months ChangeLiabilities
81.97M
▲19.19M▲30.57%
3 Months ChangeFree Cash Flow
-101.34M
▼-51.54M▼-103.49%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-03-18
Form 8-K
ID: 0001140361-24-013728
2024-03-14
Form 8-K
ID: 0001140361-24-013155
2024-03-12
Form 8-K
ID: 0001140361-24-012807
2024-03-01
Form 8-K
ID: 0001140361-24-010584
2024-02-22
Form 8-K
ID: 0000950170-24-018393
2024-01-16
Form 8-K
ID: 0000950170-24-004630
2023-12-22
Form 8-K
ID: 0001193125-23-302210
2023-12-22
Form 8-K
ID: 0001193125-23-301812
2023-11-02
Form 10-Q
ID: 0000950170-23-057731
2023-11-02
Form 8-K
ID: 0000950170-23-057729